Huxley SANSA Home Sleep Apnea Test (1000-00) vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Huxley SANSA Home Sleep Apnea Test (1000-00)

by Huxley Medical

EchoNext

by Pathway Labs

AI Verdict

Both tools are FDA-cleared AI solutions in cardiology, but they address different diagnostic needs. Huxley SANSA focuses on home sleep apnea and cardiac arrhythmia diagnosis using a wearable patch, while EchoNext analyzes standard ECGs to detect hidden structural heart disease. Therefore, the choice depends on whether the primary need is for sleep and arrhythmia monitoring or for structural heart disease screening.

Choose Huxley SANSA Home Sleep Apnea Test (1000-00) if…

Choose Huxley SANSA if you need a comprehensive, at-home solution for diagnosing sleep apnea and simultaneously monitoring for cardiac arrhythmias. Its app-free, cellular-enabled design and multi-day monitoring capability make it ideal for streamlined patient care and for identifying cardiovascular risks associated with sleep-disordered breathing.

View Huxley SANSA Home Sleep Apnea Test (1000-00) →

Choose EchoNext if…

Choose EchoNext if you need an AI-powered tool to analyze standard ECGs for the detection of hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension. It is particularly well-suited for broad screening in various clinical settings, from major hospitals to community practices, to identify patients who warrant further cardiac ultrasound evaluation.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Huxley SANSA Home Sleep Apnea Test (1000-00)	EchoNext
Pricing	Contact for pricing	Starts at $600/month
Deployment	Cloud-based algorithm with cellular data upload from device	Available through the OpenEvidence clinical decision support platform.
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Yes AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley SANSA offers a highly streamlined, app-free workflow with built-in cellular data upload, simplifying the patient experience significantly. The single-point-of-contact chest patch design is also less invasive and more comfortable than traditional sleep apnea tests, improving patient compliance.

Clinical Value

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley SANSA provides comprehensive diagnostic capabilities for both obstructive and central sleep apnea, along with cardiac arrhythmia detection, from a single device. EchoNext focuses on detecting structural heart disease from standard ECGs, which is valuable for screening, but SANSA's multi-day monitoring and broader physiological data channels offer a more holistic diagnostic picture for cardiosleep conditions.

Pricing & Value

EchoNext

EchoNext provides transparent tiered pricing starting at $600/month, with details on implementation fees and annual discounts. Huxley SANSA only states 'contact for pricing,' making it difficult to assess its cost-effectiveness without direct inquiry.

Enterprise Readiness

Tie

Both tools are FDA-cleared, HIPAA compliant, and offer BAA agreements, indicating strong foundational enterprise readiness. Huxley SANSA's app-free, cellular-enabled deployment simplifies logistics for healthcare providers, while EchoNext's availability through the OpenEvidence platform suggests established integration capabilities.

Innovation

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley SANSA's innovative wearable patch design with app-free, cellular data upload and AI-powered auto-scoring for multi-day monitoring represents a significant advancement in home sleep apnea testing. Its ability to concurrently assess sleep apnea and cardiac arrhythmias from a single patch is also a novel approach.

Support & Docs

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley SANSA explicitly mentions 24/7/365 patient support, which is crucial for home-use devices and indicates a strong commitment to user assistance. While EchoNext is deployed through a clinical decision support platform, specific details about its direct support and documentation are not provided.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Huxley SANSA Home Sleep Apnea Test (1000-00)	EchoNext
Tool Name	Huxley SANSA Home Sleep Apnea Test (1000-00)	EchoNext
Company	Huxley Medical	Pathway Labs
Description	Huxley SANSA is an FDA-cleared, AI-powered wearable patch for home sleep apnea and cardiac arrhythmia diagnosis, offering an app-free, cellular-enabled solution for streamlined patient care.	EchoNext is an FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI, Clinical Decision Support & Reference, Lab & Diagnostics
Key Features	Wearable chest patch design, App-free workflow, Built-in cellular data upload, AI-powered auto-scoring algorithms, 9 physiological data channels (ECG, SpO2, Heart Rate, Respiratory Effort, Chest Movement, Body Position, Actigraphy, Snoring, Sleep/Wake Staging), Multi-day monitoring capability, Comfortable and non-invasive, Validated against polysomnography (PSG)	AI-powered ECG analysis, Detection of hidden structural heart disease, Identifies heart failure risk, Screens for valve disease, Detects pulmonary hypertension indicators, Utilizes standard 12-lead ECGs, FDA-cleared technology, Non-invasive diagnostic support

Videos

Demos, reviews, and walkthroughs featuring Huxley SANSA Home Sleep Apnea Test (1000-00) and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

Huxley SANSA offers an app-free workflow with built-in cellular data upload, aiming to simplify the patient experience and reduce technician setup, which can streamline integration into various clinical settings, including cardiology, pulmonology, and primary care. EchoNext, on the other hand, is available through the OpenEvidence clinical decision support platform, suggesting integration within that platform's existing framework for analyzing standard 12-lead ECGs.

What is the accuracy and sensitivity of each tool in detecting relevant conditions?

Huxley SANSA has demonstrated high accuracy in detecting sleep apnea, with 95% sensitivity for sleep apnea and 99% accuracy for central sleep apnea, validated against polysomnography. EchoNext achieved an AUROC of 85% in internal tests and 78-80% in external validation for detecting structural heart disease, and in a study, it showed higher accuracy (77%) compared to cardiologists (64%) at baseline for ECG interpretations.

For which medical specialties are these tools best suited, and how do they offer multi-diagnostic potential?

Huxley SANSA is designed for cardiology, pulmonology, and sleep medicine, offering multi-day monitoring with 9 physiological data channels, including ECG, to diagnose sleep apnea and detect cardiac arrhythmias like atrial fibrillation. EchoNext is primarily for cardiology, family medicine, hospital medicine, and internal medicine, utilizing standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.

What is the learning curve for physicians and their staff when adopting these technologies?

Huxley SANSA's design as a simple, single chest-worn patch with automatic cellular data upload and no required app aims to minimize the learning curve for both patients and staff, improving patient compliance and ease of use. EchoNext analyzes standard 12-lead ECGs, which are routine tests, suggesting that the learning curve for physicians would primarily involve understanding the AI-generated insights and integrating them into their diagnostic process via the OpenEvidence platform.

What kind of support is available for physicians and patients using these tools?

Huxley Medical offers 24/7/365 patient support for SANSA, allowing care teams to focus on practice goals rather than home sleep apnea test issues. For EchoNext, while not explicitly detailed, its deployment through the OpenEvidence clinical decision support platform implies that support would likely be integrated within that platform's existing support structure.

Are there customer references or clinical trial data available to support the efficacy of these tools?

Huxley SANSA has been validated against polysomnography in a multi-site study with 340 participants, demonstrating robust diagnostic performance for OSA detection. EchoNext was developed using over one million ECG-echocardiogram pairs and has undergone internal and external validation, including a 100-patient pilot study where 73% of high-risk patients identified by EchoNext were newly diagnosed with structural heart disease.